NODE PHARMA AS
Organization
- CEO
- TE
- Chairman of the board
- TR
Thomas Ramdahl1956
- Years since formation
- 4 years
- since Apr 28, 2021
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 5
Ownership
- Number of shares and share classes
- 10,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2024
- 11,214,807
- NOK
- Annual total result 2024
- -344,152
- NOK
- Total equity 2024
- 2,752,869
- NOK
Last update: Sep 9, 2025
Management
Management / administration
Name | Role | Shares |
---|---|---|
TE | Managing Director/CEO | 33.33 % indirectly |
Board
Name | Role | Shares |
---|---|---|
EM 1989 | Board Member | 33.33 % indirectly |
TE | Board Member | 33.33 % indirectly |
SØ | Board Member | 33.33 % indirectly |
TR 1956 | Chairman | - |
Others
Name | Role | Shares |
---|---|---|
Accountant | - | |
Auditor | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
EM 1989 | Board Member | 33.33 % indirectly |
TE | Managing Director/CEO, Board Member | 33.33 % indirectly |
SØ | Board Member | 33.33 % indirectly |
Last update: Sep 4, 2025
Ownership
Company shareholders
Name | Share class | Total number of shares | Share |
---|---|---|---|
Ordinary shares | 10,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -21,402Employees: 0
Financials
in NOK
Summary
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 11,214,807 | 3,965,357 | 1,312,500 | 262,500 |
Annual Total Result | -344,152 | -1,494,231 | -581,823 | -61,355 |
Total assets | 8,096,425 | 6,538,932 | 1,129,979 | 202,553 |
Total liabilities | 5,343,556 | 5,241,911 | 1,738,727 | 229,478 |
Total equity | 2,752,869 | 1,297,021 | -608,748 | -26,925 |
P&L
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 11,214,807 | 3,965,357 | 1,312,500 | 262,500 |
Total operating costs | 11,573,253 | 5,463,384 | 1,893,862 | 323,855 |
Operating result | -358,446 | -1,498,027 | -581,362 | -61,355 |
Financial income/costs | 14,294 | 3,796 | -461 | 0 |
Profit before tax | -344,152 | -1,494,231 | -581,823 | -61,355 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -344,152 | -1,494,231 | -581,823 | -61,355 |
Balance overview
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total fixed assets | 1,419,040 | 936,963 | 88,091 | 0 |
Total current assets | 6,677,385 | 5,601,969 | 1,041,888 | 202,553 |
Total assets | 8,096,425 | 6,538,932 | 1,129,979 | 202,553 |
Short term debt | 4,490,556 | 4,363,911 | 850,727 | 29,478 |
Long term debt | 853,000 | 878,000 | 888,000 | 200,000 |
Total liabilities | 5,343,556 | 5,241,911 | 1,738,727 | 229,478 |
Contributed capital | 3,097,021 | 1,297,021 | 34,430 | 34,430 |
Retained earnings | -344,152 | 0 | -643,178 | -61,355 |
Total equity | 2,752,869 | 1,297,021 | -608,748 | -26,925 |
Total equity and liabilities | 8,096,425 | 6,538,932 | 1,129,979 | 202,553 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises